Monthly Archives: September 2019

Oculos Partner Ocuphire Pharma Announces Completion of the First of Two Phase 2b Clinical Trials

September 5, 2019 | Clinical, Ophthalmics

RUSH, NY – September 5, 2019 – Ocuphire Pharma, Inc., a clinical-stage pharmaceutical company and partner of iuvo BioScience’s ophthalmic-focused Oculos Division, announced that it has successfully enrolled 39 glaucoma patients in ORION-1 at 5 U.S. sites from late May to August 2019.  Ocuphire has been collaborating closely with Oculos Development Services to achieve these clinical […]

Podcast: iuvo CEO Ben Burton on the Legal Drugs Podcast

September 3, 2019 | Toxicology

September 3, 2019 – iuvo CEO Ben Burton was interviewed on the Legal Drugs Podcast in the most recent episode (episode 5) which became available September 2. The interview took place at the 2019 Society of Toxicology meeting, and provided an opportunity for Ben to speak with Legal Drugs Podcast host Angela Stoyanovitch on testing […]